한국지질동맥경화학회 학술대회

This joint symposium, “Familial Hypercholesterolemia in the Era of Precision Medicine,” brings together experts from Korea, Japan, and Taiwan to explore cutting-edge strategies in FH care. The session will begin with an update on advances in FH management beyond statins, followed by a presentation on the role of genetic screening and cascade testing for early detection. A third lecture will address the question of cardiovascular risk in FH, focusing on how early intervention should be considered. The symposium will conclude with a panel discussion, providing an opportunity to share perspectives and experiences across the three countries, and to highlight the potential of precision medicine in shaping personalized management of FH.